4.8 Article

Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity

期刊

CANCER RESEARCH
卷 75, 期 17, 页码 3505-3518

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-15-0139

关键词

-

类别

资金

  1. Cancer Center Core Grant [CA16672, CA124782, CA120956, CA141303, CA148600]
  2. Center for Clinical and Translational Sciences
  3. National Center for Advancing Translational Sciences of the NIH [TL1TR000369]
  4. SPORE [P50 CA136411]
  5. Albert J Ward Foundation
  6. Alex Lemonade Stand Foundation
  7. American Legion Auxiliary
  8. Burroughs Wellcome Fund
  9. Cancer Answers
  10. Cancer Prevention and Research Institute of Texas
  11. Charles B. Goddard Foundation of Texas
  12. CLL Global Research Foundation
  13. DARPA (Defense Sciences Office)
  14. Department of Defense
  15. Estate of Noelan L. Bibler
  16. Gillson Longenbaugh Foundation
  17. Harry T. Mangurian, Jr, Fund for Leukemia Immunotherapy
  18. Khalifa Bin Zayed Al Nahyan Foundation
  19. Leukemia and Lymphoma Society
  20. Lymphoma Research Foundation
  21. Miller Foundation
  22. Moon Shot program at MDACC
  23. Mr. Herb Simons
  24. Mr. and Mrs. Joe H. Scales
  25. Mr. Thomas Scott
  26. National Foundation for Cancer Research
  27. Pediatric Cancer Research Foundation
  28. Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  29. R.W. Butcher Foundation
  30. MDACC Sister Institution Network Fund
  31. Moon Shot Fund
  32. William Lawrence and Blanche Hughes Children's Foundation

向作者/读者索取更多资源

Many tumors overexpress tumor-associated antigens relative to normal tissue, such as EGFR. This limits targeting by human T cells modified to express chimeric antigen receptors (CAR) due to potential for deleterious recognition of normal cells. We sought to generate CAR(+) T cells capable of distinguishing malignant from normal cells based on the disparate density of EGFR expression by generating two CARs from monoclonal antibodies that differ in affinity. T cells with low-affinity nimotuzumab-CAR selectively targeted cells overexpressing EGFR, but exhibited diminished effector function as the density of EGFR decreased. In contrast, the activation of T cells bearing high-affinity cetuximab-CAR was not affected by the density of EGFR. In summary, we describe the generation of CARs able to tune T-cell activity to the level of EGFR expression in which a CAR with reduced affinity enabled T cells to distinguish malignant from nonmalignant cells. (C)2015 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据